Status: current, Defined. Date: 31-Jan 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1507241000168117 | Diane-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4136981000168114 | Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4145571000168110 | Diane-35 ED (cyproterone acetate 2 mg + ethinyloestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | Is a | Diane-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | true | Inferred relationship | Some | ||
| Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | has TPUU | Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | true | Inferred relationship | Some | 1 | |
| Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | has TPUU | Diane-35 ED (inert substance) tablet | true | Inferred relationship | Some | 2 | |
| Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | has container type | blister pack | true | Inferred relationship | Some | ||
| Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | has TP | Diane-35 ED | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Diane-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs | has subpack | True | Diane-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | Inferred relationship | Some | 1 |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR